Skip to content

Effectiveness of Enhanced Treatments for Drug Dependence

Effectiveness of an Enhanced Adaptive Continuing Care Model for Cocaine Dependence

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01153477
Acronym
EETDD
Enrollment
150
Registered
2010-06-30
Start date
2009-10-31
Completion date
2011-10-31
Last updated
2017-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cocaine Dependence

Brief summary

The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boost patient involvement and community linkages. The investigators will recruit 150 cocaine dependent patients in publicly funded, community-based programs and randomize them to treatment as usual or the TMAC-E and follow them for 12 months.

Interventions

BEHAVIORALTelephone Monitoring and Counseling - Enhanced

Calls or in-person sessions, 1x weekly for first 8 weeks, then every other week up to a year. Step up session frequency if needed based on participants' ratio of protective and risk factors.

Sponsors

University of Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* (1) qualify for a DSM-IV diagnosis of cocaine dependence, with some cocaine use in the prior 6 months; * (2) be 18 to 75 years of age; * (3) have no current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment; * (4) have no acute medical problem requiring immediate inpatient treatment; * (5) not be in methadone or other modes of Drug and Alcohol treatment, other than Intensive Outpatient Program; * (6) be willing to be randomized and participate in research; * (7) because of study follow-up requirements, subjects will be able to provide the name, verified telephone number, and address of at least one contact who can provide locator information on the patient during follow-up. We will include patients with dependence on other substances, provided that they are cocaine dependent and meet other inclusion criteria.

Exclusion criteria

* have a current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment; * have acute medical problem requiring immediate inpatient treatment; * are in methadone or other modes of DA treatment, other than IOP; * or cannot provide names of people who can get messages to them for follow up, in the event we cannot locate the participant at their original address and number. Also, if they are court mandated to treatment or otherwise considered a prisoner, they will be ineligible for the study as we have not applied for Subpart C approval.

Design outcomes

Primary

MeasureTime frameDescription
Time Line Follow Back3 monthabstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026